A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects
Clinical trial NCT01284309 · COMPLETED
Trial details
- NCT number
- NCT01284309
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-02-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.